Fisher And Paykel Healthcare Corpo revenue and financials
In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of 2.31B id:5 (+14.22% year over year). Net income was 468.5M id:5, a net margin of 20.3%.
Fiscal year ending in March. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +14.22%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +24.20%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 20.3%
- FY to Mar 2025: 18.7%
How Fisher And Paykel Healthcare Corpo is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 3.2% a year on average over the last 5 years
Compound annual growth rate: from 1.97B id:5 in 2021 to 2.31B id:5 in 2026.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2026.
Operating margin rose from 21.0% to 27.6%
Operating income over revenue, 2023 → 2026: 6.6 percentage points.
Profits turn into cash: free cash flow equal to 103% of net income
Totals for fiscal years 2024–2026: free cash flow 1B id:5, net income 978.3M id:5.
Financial data
Amounts in millions of id:5; per-share values in id:5; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,308 | 2,021 | 1,743 | 1,581 | 1,682 | 1,971 | 1,264 | 1,070 | 981 | 894 |
| Cost of revenue | 838 | 750 | 698 | 643 | 629 | 726 | 428 | 355 | 330 | 304 |
| Gross profit | 1,470 | 1,271 | 1,044 | 938 | 1,053 | 1,246 | 836 | 716 | 650 | 590 |
| Selling, general and administrative | 598 | 534 | 493 | 432 | 393 | 397 | 338 | 304 | 291 | 269 |
| Research and development | 236 | 227 | 198 | 174 | 154 | 137 | 119 | 100 | 94.7 | 86.0 |
| Operating income | 636 | 510 | 353 | 332 | 506 | 712 | 379 | 316 | 270 | 240 |
| EBIT | 636 | 510 | 353 | 332 | 506 | 712 | 379 | 316 | 270 | 240 |
| EBITDA | 759 | 623 | 445 | 410 | 579 | 781 | 426 | 354 | 311 | 276 |
| Interest expense | 10.3 | 11.1 | 18.2 | 6.7 | 4.9 | 5.0 | 3.9 | 2.5 | 3.7 | 3.5 |
| Pre-tax income | 632 | 503 | 236 | 328 | 504 | 718 | 371 | 291 | 268 | 239 |
| Income tax | 163 | 126 | 103 | 77.7 | 127 | 194 | 83.2 | 82.0 | 77.6 | 69.3 |
| Net income | 469 | 377 | 133 | 250 | 377 | 524 | 287 | 209 | 190 | 169 |
| Net income to common shareholders | 469 | 377 | 133 | 250 | 377 | 524 | 287 | 209 | 190 | 169 |
| Basic EPS | 0.80 | 0.64 | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.37 | 0.33 | 0.30 |
| Diluted EPS | 0.79 | 0.64 | 0.23 | 0.43 | 0.65 | 0.90 | 0.50 | 0.36 | 0.33 | 0.30 |
| Average shares (basic) | 587 | 586 | 582 | 578 | 577 | 576 | 574 | 573 | 570 | 566 |
| Average shares (diluted) | 591 | 590 | 586 | 582 | 580 | 580 | 579 | 578 | 576 | 574 |
| Dividend per share | 0.52 | 0.43 | 0.42 | 0.41 | 0.40 | 0.38 | 0.28 | 0.23 | 0.21 | 0.20 |
Amounts in millions of id:5; per-share values in id:5; shares in millions.
| Item | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,220 | 1,089 | 1,070 | 951 | 939 | 804 | 891 | 691 | 782 | 900 |
| Cost of revenue | 436 | 403 | 388 | 363 | 381 | 318 | 365 | 277 | 297 | 332 |
| Gross profit | 784 | 686 | 682 | 589 | 558 | 486 | 525 | 413 | 485 | 568 |
| Selling, general and administrative | 313 | 286 | 274 | 261 | 256 | 237 | 230 | 202 | 204 | 190 |
| Research and development | 121 | 114 | 117 | 110 | 101 | 96.9 | 90.1 | 84.2 | 78.3 | 75.7 |
| Operating income | 350 | 286 | 292 | 218 | 201 | 153 | 206 | 127 | 203 | 302 |
| EBIT | 350 | 286 | 292 | 218 | 201 | 153 | 206 | 127 | 203 | 302 |
| EBITDA | 410 | 350 | 347 | 276 | 246 | 198 | 240 | 170 | 237 | 342 |
| Interest expense | 4.8 | 5.5 | 6.2 | 4.9 | 9.5 | 8.7 | 5.5 | 1.2 | 2.5 | 2.4 |
| Pre-tax income | 348 | 284 | 297 | 206 | 95.1 | 141 | 214 | 114 | 203 | 301 |
| Income tax | 92.2 | 70.8 | 72.9 | 53.2 | 69.8 | 33.3 | 59.3 | 18.4 | 48.0 | 79.3 |
| Net income | 256 | 213 | 224 | 153 | 25.3 | 107 | 154 | 95.9 | 155 | 222 |
| Net income to common shareholders | 256 | 213 | 224 | 153 | 25.3 | 107 | 154 | 95.9 | 155 | 222 |
| Basic EPS | 0.44 | 0.36 | 0.38 | 0.26 | 0.04 | 0.18 | 0.27 | 0.17 | 0.27 | 0.38 |
| Diluted EPS | 0.43 | 0.36 | 0.38 | 0.26 | 0.04 | 0.18 | 0.26 | 0.16 | 0.27 | 0.38 |
| Average shares (basic) | 587 | 587 | 586 | 585 | 583 | 581 | 579 | 577 | 577 | 577 |
| Average shares (diluted) | 591 | 591 | 591 | 589 | 588 | 585 | 583 | 581 | 580 | 580 |
| Dividend per share | 0.33 | 0.19 | 0.24 | 0.19 | 0.24 | 0.18 | 0.23 | 0.18 | 0.23 | 0.17 |
Amounts in millions of id:5; per-share values in id:5; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,854 | 2,551 | 2,282 | 2,205 | 2,107 | 2,075 | 1,435 | 1,207 | 1,025 | 878 |
| Current assets | 1,152 | 935 | 705 | 774 | 888 | 920 | 519 | 455 | 424 | 349 |
| Cash and equivalents | 461 | 265 | 82.0 | 121 | 89.9 | 97.3 | 67.1 | 48.2 | 31.9 | 61.3 |
| Short-term investments | — | — | — | — | 200 | 280 | 77.7 | 92.5 | 100 | — |
| Receivables | 343 | 318 | 266 | 254 | 183 | 229 | 223 | 159 | 148 | 132 |
| Inventory | 327 | 343 | 320 | 366 | 359 | 271 | 147 | 136 | 125 | 135 |
| Net property, plant and equipment | 1,407 | 1,339 | 1,340 | 1,148 | 958 | 882 | 735 | 601 | 476 | 425 |
| Other intangible assets | 72.7 | 82.1 | 88.4 | 85.6 | 86.8 | 80.0 | 73.9 | 61.5 | 50.4 | 44.5 |
| Long-term investments | — | — | — | 0.3 | 0.1 | — | — | 0.4 | 0.9 | 0.6 |
| Current liabilities | 498 | 500 | 385 | 290 | 304 | 428 | 335 | 184 | 178 | 146 |
| Accounts payable | 56.7 | 52.9 | 32.4 | 43.0 | 53.8 | 56.7 | 69.3 | 55.1 | 32.7 | 29.3 |
| Long-term debt | 52.5 | — | 35.7 | 79.1 | 63.0 | 63.7 | 23.6 | 69.3 | 52.7 | 40.3 |
| Total debt | 139 | 149 | 188 | 142 | 99.0 | 108 | 108 | 69.5 | 66.6 | 46.2 |
| Total liabilities | 738 | 660 | 523 | 451 | 427 | 554 | 461 | 294 | 264 | 217 |
| Total equity (incl. minority) | 2,115 | 1,890 | 1,759 | 1,753 | 1,680 | 1,521 | 974 | 913 | 761 | 662 |
| Retained earnings | 1,443 | 1,227 | 1,095 | 1,201 | 1,181 | 1,029 | 686 | 549 | 467 | 391 |
Amounts in millions of id:5; per-share values in id:5; shares in millions.
| Item | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,854 | 2,631 | 2,551 | 2,435 | 2,282 | 2,390 | 2,205 | 2,095 | 2,107 | 2,045 |
| Current assets | 1,152 | 984 | 935 | 768 | 705 | 729 | 774 | 724 | 888 | 868 |
| Cash and equivalents | 461 | 300 | 265 | 117 | 82.0 | 70.5 | 121 | 69.8 | 89.9 | 103 |
| Short-term investments | — | — | — | — | — | — | — | — | 200 | 185 |
| Receivables | 343 | 331 | 318 | 268 | 266 | 262 | 254 | 223 | 183 | 249 |
| Inventory | 327 | 337 | 343 | 333 | 320 | 360 | 366 | 398 | 359 | 292 |
| Net property, plant and equipment | 1,407 | 1,340 | 1,339 | 1,336 | 1,340 | 1,419 | 1,148 | 1,045 | 958 | 917 |
| Other intangible assets | 72.7 | 77.2 | 82.1 | 82.9 | 88.4 | 85.5 | 85.6 | 88.3 | 86.8 | 83.5 |
| Long-term investments | — | — | — | — | — | — | 0.3 | — | 0.1 | — |
| Current liabilities | 498 | 471 | 500 | 373 | 385 | 287 | 290 | 369 | 304 | 314 |
| Accounts payable | 56.7 | 268 | 52.9 | 229 | 32.4 | 213 | 43.0 | 205 | 53.8 | 225 |
| Long-term debt | 52.5 | — | — | — | 35.7 | 237 | 79.1 | 70.0 | 63.0 | 63.5 |
| Total debt | 139 | 141 | 149 | 151 | 188 | 318 | 142 | 125 | 99.0 | 106 |
| Total liabilities | 738 | 645 | 660 | 506 | 523 | 638 | 451 | 616 | 427 | 455 |
| Total equity (incl. minority) | 2,115 | 1,986 | 1,890 | 1,930 | 1,759 | 1,752 | 1,753 | 1,478 | 1,680 | 1,591 |
| Retained earnings | 1,443 | 1,299 | 1,227 | 1,111 | 1,095 | 1,175 | 1,201 | 1,147 | 1,181 | 1,124 |
Amounts in millions of id:5; per-share values in id:5; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 663 | 549 | 430 | 238 | 324 | 625 | 321 | 253 | 248 | 194 |
| Depreciation and amortization | 149 | 134 | 109 | 93.9 | 86.7 | 80.5 | 56.4 | 37.8 | 41.0 | 35.8 |
| Capital expenditure | -173 | -73.6 | -317 | -188 | -138 | -160 | -145 | -115 | -83.2 | -47.9 |
| Investing cash flow | -195 | -103 | -339 | -11.3 | -89.5 | -387 | -156 | -126 | -199 | -62.9 |
| Financing cash flow | -277 | -268 | -129 | -197 | -236 | -188 | -159 | -113 | -79.1 | -87.8 |
| Dividends paid | -224 | -168 | -119 | -171 | -201 | -161 | -130 | -101 | -91.8 | -79.9 |
| Debt issued | 52.5 | 107 | 301 | 138 | 7.5 | 45.3 | 15.0 | 40.1 | 31.4 | — |
| Debt repaid | -81.1 | -182 | -287 | -142 | -21.6 | -55.5 | -29.9 | -40.7 | -9.8 | — |
| Effect of exchange rates | 2.3 | 1.9 | 2.2 | 2.4 | 0.2 | -1.0 | -1.2 | 0.6 | — | 0.2 |
| Net change in cash | 194 | 179 | -35.9 | 32.2 | -0.8 | 49.0 | 5.5 | 15.1 | -29.8 | 43.1 |
| Free cash flow | 468 | 446 | 90.6 | 26.9 | — | — | — | — | — | — |
| Levered free cash flow | 399 | 437 | 45.7 | 26.9 | 78.2 | 340 | 146 | 106 | 138 | 100 |
Amounts in millions of id:5; per-share values in id:5; shares in millions.
| Item | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 417 | 246 | 316 | 233 | 273 | 157 | 236 | 1.9 | 197 | 128 |
| Depreciation and amortization | 74.5 | 74.9 | 66.4 | 67.4 | 54.7 | 54.4 | 43.4 | 50.5 | 40.7 | 46.0 |
| Capital expenditure | -121 | -52.0 | -34.0 | -39.6 | -52.9 | -264 | -75.8 | -112 | -73.6 | -64.8 |
| Investing cash flow | -133 | -61.8 | -47.9 | -55.1 | -63.5 | -276 | -86.5 | 75.2 | -103 | 13.8 |
| Financing cash flow | -124 | -153 | -131 | -137 | -195 | 66.0 | -89.6 | -108 | -104 | -132 |
| Dividends paid | -108 | -116 | -96.1 | -72.1 | -52.0 | -67.3 | -64.0 | -107 | -96.1 | -104 |
| Debt issued | 52.5 | — | 66.8 | 40.0 | 90.6 | 210 | 110 | 27.5 | 7.5 | — |
| Debt repaid | -66.5 | -14.6 | -91.0 | -91.2 | -223 | -63.5 | -135 | -6.7 | -15.0 | -6.6 |
| Effect of exchange rates | 0.5 | 1.8 | 7.0 | -5.1 | 1.4 | 0.8 | -4.2 | 6.6 | 0.6 | -0.4 |
| Net change in cash | 161 | 32.9 | 144 | 35.6 | 16.3 | -52.2 | 56.0 | -23.8 | -9.8 | 9.0 |
| Free cash flow | — | — | 446 | — | — | — | — | — | — | — |
| Levered free cash flow | 245 | 154 | 318 | 119 | 184 | -138 | 50.2 | -23.3 | 68.8 | 9.4 |
Financial statements of similar companies
Companies in the group: same industry, similar size
